Cargando…
Clearance of therapeutic antibody glycoforms after subcutaneous and intravenous injection in a porcine model
A relatively low clearance is one of the prominent favorable features of immunoglobulin G1-based therapeutic monoclonal antibodies (mAbs). Various studies have observed differential clearance of mAb glycoforms, including oligomannose glycoforms, which are considered a critical quality attribute beca...
Autores principales: | Falck, David, Lechmann, Martin, Momčilović, Ana, Thomann, Marco, Koeleman, Carolien A. M., Jany, Cordula, Malik, Sebastian, Wuhrer, Manfred, Reusch, Dietmar |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Taylor & Francis
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9673920/ https://www.ncbi.nlm.nih.gov/pubmed/36383465 http://dx.doi.org/10.1080/19420862.2022.2145929 |
Ejemplares similares
-
Glycoform-resolved pharmacokinetic studies in a rat model employing glycoengineered variants of a therapeutic monoclonal antibody
por: Falck, David, et al.
Publicado: (2020) -
Glycoform-resolved FcɣRIIIa affinity chromatography–mass spectrometry
por: Lippold, Steffen, et al.
Publicado: (2019) -
Affinity capillary electrophoresis – mass spectrometry permits direct binding assessment of IgG and FcγRIIa in a glycoform-resolved manner
por: Gstöttner, Christoph, et al.
Publicado: (2022) -
Decreased Levels of Bisecting GlcNAc Glycoforms of IgG Are Associated with Human Longevity
por: Ruhaak, L. Renee, et al.
Publicado: (2010) -
Natural Glycoforms of Human Interleukin 6 Show Atypical Plasma Clearance
por: Reif, Andreas, et al.
Publicado: (2021)